Evidence map›Paper›PMID 33981223›Full record

ArticleFrontiers in pharmacology2021

Novel Murine Biomarkers of Radiation Exposure Using An Aptamer-Based Proteomic Technology.

Mary Sproull, Uma Shankavaram, Kevin Camphausen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.Radiation (Multidisciplinary Digital Publishing Institute) · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mary SproullRadiation Oncology Branch, National Cancer Institute, Bethesda, MD, United States.
Uma ShankavaramRadiation Oncology Branch, National Cancer Institute, Bethesda, MD, United States.
Kevin CamphausenRadiation Oncology Branch, National Cancer Institute, Bethesda, MD, United States.
National Cancer Institute · US

Funding

The Synergy Between Radiotherapy and Molecularly Targeted AgentsZIASC010373 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI CAMPHAUSEN, KEVIN · 2009 to 2025
$22.2M
Radiation Oncology Branch - Microarray FacilityZICBC010991 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CAMPHAUSEN, KEVIN · 2009 to 2025
$13.8M
Intramural NIH HHS ZIA SC010373
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biodosimetrybiomarkermedical countermeasureradiationsomascan

Identifiers

PMID33981223
PMCPMC8110031
OpenAlexW3159054591

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.